In the News

Primatene Mist No Longer Available After Dec. 31

Bookmark and Share

April 4, 2011

The FDA is asking its health care colleagues to remind the public about the phase-out of epinephrine CFC metered dose inhalers. Commonly marketed as Primatene Mist, this medicine will be phased out by December 31, 2011.

The FDA is encouraging us to remind consumers that the most effective way to control asthma is to work closely with a clinician to determine appropriate treatment. You can read the full consumer alert on the FDA website.